Management of Mixed Dyslipidemia

Diagnosis and Characteristics

• Mixed dyslipidemia is characterized by elevated LDL cholesterol and elevated triglycerides, often with decreased HDL cholesterol 1

Statin Selection

• The American College of Cardiology recommends atorvastatin (40-80 mg) for mixed dyslipidemia, providing ≥50% LDL-C reduction and significant triglyceride lowering 2, 3
• Rosuvastatin (20-40 mg) is also recommended, providing ≥50% LDL-C reduction 2, 3

Treatment Algorithm

• Initial therapy for mixed dyslipidemia should be high-intensity statin (preferably atorvastatin 40-80 mg) 2, 3, 4
• If triglycerides remain high despite statin therapy, optimize glycemic control and consider adding a fibrate (preferably fenofibrate) 1, 5
• Alternative: Consider adding ezetimibe if LDL-C remains above target 6

Monitoring and Follow-up

• Check lipid profile 4-12 weeks after initiating therapy and monitor every 6-12 months once goals are achieved 4
• Monitor for muscle symptoms and liver function abnormalities 2, 3

Special Populations

• In diabetic patients, glycemic control should be the first priority for triglyceride management, followed by statin therapy 1
• For severe hypertriglyceridemia, consider starting with a fibrate to reduce pancreatitis risk before addressing LDL-C 4, 6